The Clinical Outcome and the Cost-effectiveness Analysis of Simvastatin Plus Standard Therapy Versus Standard Therapy Alone in Critically Ill Septic Patient

Trial Profile

The Clinical Outcome and the Cost-effectiveness Analysis of Simvastatin Plus Standard Therapy Versus Standard Therapy Alone in Critically Ill Septic Patient

Completed
Phase of Trial: Phase III

Latest Information Update: 08 Apr 2015

At a glance

  • Drugs Simvastatin (Primary)
  • Indications Sepsis
  • Focus Therapeutic Use
  • Most Recent Events

    • 03 Apr 2015 Status changed from recruiting to completed as reported by ClinicalTrial.gov record.
    • 19 Mar 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top